Try small and more frequent meals
Hypokalemia Risk: A rise in red blood cell formation in previously severely anemic patients can predispose them to hypokalemia
Metabolic issues: Feeling constantly cold, chills, or a low body temperature (signs of metabolic acidosis) Severe gastrointestinal changes: Persistent diarrhea, vomiting, or a total loss of appetite Systemic changes: Unexplained tiredness, a fever or other signs of infection, unusual bleeding, bruising, or long-term concerns like osteoporosis In general, higher doses of topiramate are associated with an increased risk of adverse reactions
P., Schmidt, I
4.4.3 Iron chelators as ferroptosis inhibitors in PD therapy Targeting ferroptosis through iron chelation represents a promising therapeutic approach in PD
PCAC will review 7 peptides for the 503A bulks list, BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax, Epitalon